Cytodyn Inc (CYDY)

[Saltz]

Wallstreet, I agree with your logic.

IMO, the challenge is compressing enough good news into a short enough period of time to create enough momentum to get us over $2 and out of the manipulative and restrictive OTC space. CROI, BTD Approval, ODD approval, primary endpoint P3, 100% rollover opting for extension are all on the radar. In addition hopefully an expedited P3 Mono Enrollment to name a few. The tipping point is upon us. You know Nader has to be thinking they can hit a couple of these catalysts and boost SP before the next raise.

This is like going on a really long whitewater rafting trip and up to this point it's been relatively calm waters with a few Class 1 and 2 rapids mixed in. We are now approaching the last part of the float which concludes with Class 5 water-where it ALL goes down...the reason why I decided to take the rafting trip in the first place...to be part of something extraordinary.